[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Biologic Drugs Sales Market Report 2017

October 2017 | 101 pages | ID: G17DD2538B1PEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Biologic Drugs market competition by top manufacturers/players, with Biologic Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Roche
  • Abbott Laboratories
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Amgen
  • Sanofi
  • Novartis
  • Eli Lilly
  • Amgen
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Humira
  • Remicade
  • Rituxan
  • Enbrel
  • Lantus
  • Avastin
  • Herceptin
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biologic Drugs for each application, including
  • Diabetes
  • Inflammation
  • Auto-Immune Diseases
  • Blood Diseases
  • Cardiovascular Diseases
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Biologic Drugs Sales Market Report 2017

1 BIOLOGIC DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologic Drugs
1.2 Classification of Biologic Drugs by Product Category
  1.2.1 Global Biologic Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Biologic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Humira
  1.2.4 Remicade
  1.2.5 Rituxan
  1.2.6 Enbrel
  1.2.7 Lantus
  1.2.8 Avastin
  1.2.9 Herceptin
  1.2.10 Others
1.3 Global Biologic Drugs Market by Application/End Users
  1.3.1 Global Biologic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Diabetes
  1.3.3 Inflammation
  1.3.4 Auto-Immune Diseases
  1.3.5 Blood Diseases
  1.3.6 Cardiovascular Diseases
  1.3.7 Others
1.4 Global Biologic Drugs Market by Region
  1.4.1 Global Biologic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Biologic Drugs Status and Prospect (2012-2022)
  1.4.3 China Biologic Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Biologic Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Biologic Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Biologic Drugs Status and Prospect (2012-2022)
  1.4.7 India Biologic Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biologic Drugs (2012-2022)
  1.5.1 Global Biologic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Biologic Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL BIOLOGIC DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Biologic Drugs Market Competition by Players/Suppliers
  2.1.1 Global Biologic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Biologic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Biologic Drugs (Volume and Value) by Type
  2.2.1 Global Biologic Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Biologic Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Biologic Drugs (Volume and Value) by Region
  2.3.1 Global Biologic Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Biologic Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Biologic Drugs (Volume) by Application

3 UNITED STATES BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biologic Drugs Sales and Value (2012-2017)
  3.1.1 United States Biologic Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Biologic Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Biologic Drugs Sales Price Trend (2012-2017)
3.2 United States Biologic Drugs Sales Volume and Market Share by Players
3.3 United States Biologic Drugs Sales Volume and Market Share by Type
3.4 United States Biologic Drugs Sales Volume and Market Share by Application

4 CHINA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Biologic Drugs Sales and Value (2012-2017)
  4.1.1 China Biologic Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Biologic Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Biologic Drugs Sales Price Trend (2012-2017)
4.2 China Biologic Drugs Sales Volume and Market Share by Players
4.3 China Biologic Drugs Sales Volume and Market Share by Type
4.4 China Biologic Drugs Sales Volume and Market Share by Application

5 EUROPE BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Biologic Drugs Sales and Value (2012-2017)
  5.1.1 Europe Biologic Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Biologic Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Biologic Drugs Sales Price Trend (2012-2017)
5.2 Europe Biologic Drugs Sales Volume and Market Share by Players
5.3 Europe Biologic Drugs Sales Volume and Market Share by Type
5.4 Europe Biologic Drugs Sales Volume and Market Share by Application

6 JAPAN BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biologic Drugs Sales and Value (2012-2017)
  6.1.1 Japan Biologic Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Biologic Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Biologic Drugs Sales Price Trend (2012-2017)
6.2 Japan Biologic Drugs Sales Volume and Market Share by Players
6.3 Japan Biologic Drugs Sales Volume and Market Share by Type
6.4 Japan Biologic Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biologic Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Biologic Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Biologic Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Biologic Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Biologic Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Biologic Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Biologic Drugs Sales Volume and Market Share by Application

8 INDIA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Biologic Drugs Sales and Value (2012-2017)
  8.1.1 India Biologic Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Biologic Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Biologic Drugs Sales Price Trend (2012-2017)
8.2 India Biologic Drugs Sales Volume and Market Share by Players
8.3 India Biologic Drugs Sales Volume and Market Share by Type
8.4 India Biologic Drugs Sales Volume and Market Share by Application

9 GLOBAL BIOLOGIC DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Roche
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biologic Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biologic Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Johnson & Johnson
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biologic Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Merck & Co.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biologic Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Pfizer
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Biologic Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Amgen
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Biologic Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Sanofi
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Biologic Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Novartis
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Biologic Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Eli Lilly
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Biologic Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Amgen
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Biologic Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 BIOLOGIC DRUGS MAUFACTURING COST ANALYSIS

10.1 Biologic Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biologic Drugs
10.3 Manufacturing Process Analysis of Biologic Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biologic Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologic Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOLOGIC DRUGS MARKET FORECAST (2017-2022)

14.1 Global Biologic Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Biologic Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Biologic Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Biologic Drugs Price and Trend Forecast (2017-2022)
14.2 Global Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Biologic Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Biologic Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biologic Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Biologic Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Biologic Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Biologic Drugs Price Forecast by Type (2017-2022)
14.4 Global Biologic Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Biologic Drugs
Figure Global Biologic Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Biologic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Humira Product Picture
Figure Remicade Product Picture
Figure Rituxan Product Picture
Figure Enbrel Product Picture
Figure Lantus Product Picture
Figure Avastin Product Picture
Figure Herceptin Product Picture
Figure Others Product Picture
Figure Global Biologic Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Biologic Drugs by Application in 2016
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Auto-Immune Diseases Examples
Table Key Downstream Customer in Auto-Immune Diseases
Figure Blood Diseases Examples
Table Key Downstream Customer in Blood Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Biologic Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biologic Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Biologic Drugs Sales Volume (K Units) (2012-2017)
Table Global Biologic Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Biologic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Biologic Drugs Sales Share by Players/Suppliers
Figure 2017 Biologic Drugs Sales Share by Players/Suppliers
Figure Global Biologic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biologic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biologic Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Biologic Drugs Revenue Share by Players
Table 2017 Global Biologic Drugs Revenue Share by Players
Table Global Biologic Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Biologic Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Biologic Drugs by Type (2012-2017)
Figure Global Biologic Drugs Sales Growth Rate by Type (2012-2017)
Table Global Biologic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Biologic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Type (2012-2017)
Figure Global Biologic Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Biologic Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Biologic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Biologic Drugs by Region (2012-2017)
Figure Global Biologic Drugs Sales Growth Rate by Region in 2016
Table Global Biologic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biologic Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Region (2012-2017)
Figure Global Biologic Drugs Revenue Growth Rate by Region in 2016
Table Global Biologic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biologic Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Region (2012-2017)
Figure Global Biologic Drugs Revenue Market Share by Region in 2016
Table Global Biologic Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Biologic Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Biologic Drugs by Application (2012-2017)
Figure Global Biologic Drugs Sales Market Share by Application (2012-2017)
Figure United States Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Biologic Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Biologic Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Biologic Drugs Sales Volume Market Share by Players in 2016
Table United States Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Biologic Drugs Sales Volume Market Share by Type in 2016
Table United States Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Biologic Drugs Sales Volume Market Share by Application in 2016
Figure China Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Biologic Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Biologic Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Biologic Drugs Sales Volume Market Share by Players in 2016
Table China Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Biologic Drugs Sales Volume Market Share by Type in 2016
Table China Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Europe Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Biologic Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Biologic Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Biologic Drugs Sales Volume Market Share by Players in 2016
Table Europe Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Biologic Drugs Sales Volume Market Share by Type in 2016
Table Europe Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Japan Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Biologic Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Biologic Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Biologic Drugs Sales Volume Market Share by Players in 2016
Table Japan Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Biologic Drugs Sales Volume Market Share by Type in 2016
Table Japan Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Application in 2016
Figure India Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Biologic Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Biologic Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Biologic Drugs Sales Volume Market Share by Players in 2016
Table India Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Biologic Drugs Sales Volume Market Share by Type in 2016
Table India Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Biologic Drugs Sales Volume Market Share by Application in 2016
Table Roche Basic Information List
Table Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biologic Drugs Sales Growth Rate (2012-2017)
Figure Roche Biologic Drugs Sales Global Market Share (2012-2017
Figure Roche Biologic Drugs Revenue Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Biologic Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Biologic Drugs Sales Global Market Share (2012-2017
Figure Abbott Laboratories Biologic Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologic Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Biologic Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Biologic Drugs Revenue Global Market Share (2012-2017)
Table Merck & Co. Basic Information List
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Biologic Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co. Biologic Drugs Sales Global Market Share (2012-2017
Figure Merck & Co. Biologic Drugs Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biologic Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Biologic Drugs Sales Global Market Share (2012-2017
Figure Pfizer Biologic Drugs Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biologic Drugs Sales Growth Rate (2012-2017)
Figure Amgen Biologic Drugs Sales Global Market Share (2012-2017
Figure Amgen Biologic Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Biologic Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Biologic Drugs Sales Global Market Share (2012-2017
Figure Sanofi Biologic Drugs Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Biologic Drugs Sales Growth Rate (2012-2017)
Figure Novartis Biologic Drugs Sales Global Market Share (2012-2017
Figure Novartis Biologic Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biologic Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Biologic Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly Biologic Drugs Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biologic Drugs Sales Growth Rate (2012-2017)
Figure Amgen Biologic Drugs Sales Global Market Share (2012-2017
Figure Amgen Biologic Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologic Drugs
Figure Manufacturing Process Analysis of Biologic Drugs
Figure Biologic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Biologic Drugs Major Players in 2016
Table Major Buyers of Biologic Drugs
Table Distributors/Traders List
Figure Global Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biologic Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Biologic Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Biologic Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Biologic Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Biologic Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Biologic Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Biologic Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Biologic Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Biologic Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Biologic Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Biologic Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biologic Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Biologic Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Biologic Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Biologic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories